An investigation for investors in NASDAQ:TBIO shares was announced over potential breaches of fiduciary duties by certain officers and directors at Omaha, NE based Transgenomic.
Investors who purchased shares of Transgenomic Inc (NASDAQ:TBIO) and currently hold any of those NASDAQ:TBIO shares have certain options and should contact the Shareholders Foundation at firstname.lastname@example.org or call +1(858) 779 – 1554.
The investigation by a law firm concerns whether certain Transgenomic officers and directors breached their fiduciary duties and caused damage to the company and its shareholders.
Biotechnology company Transgenomic Inc reported that its annual Total Revenue declined from $27.54 million in 2013 to $1.24 million in 2014, respectively $1.65 million in 2015.
Shares of Transgenomic Inc (NASDAQ:TBIO) declined from $4.00 per share in early 2014 to as low as $0.48 per share on May 13, 2016.
On June 15, 2016, NASDAQ:TBIO shares closed at $0.61 per share.
Those who purchased NASDAQ:TBIO shares have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North – Suite 423
92108 San Diego